Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 146.549
Filter
1.
Longit Life Course Stud ; 15(3): 286-321, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38954421

ABSTRACT

In the United Kingdom, the COVID-19 pandemic in 2020 and 2021 led to two extended periods of school closures. Research on inequality of learning opportunity as a result of these closures used a single indicator of socio-economic status, neglecting important determinants of remote learning. Using data from the Understanding Society (USoc) COVID-19 surveys we analysed the levels and differentials in the uptake of remote schoolwork using parental social class, information technology (IT) availability in the home and parental working patterns to capture the distinct resources that families needed to complete remote schoolwork. This is also the first study to assess the extent to which the differentials between socio-economic groups changed between the first and second school-closure periods caused by the pandemic. We found that each of the three factors showed an independent association with the volume of remote schoolwork and that their effect was magnified by their combination. Children in families where the main parent was in an upper-class occupation, where both parents worked from home and where the children had their own IT spent more time doing remote schoolwork than other groups, particularly compared to children of single parents who work from home, children in families where the main parent was in a working-class occupation, where the child had to share IT, and where the parents did not work regularly from home. The differentials between socio-economic groups in the uptake of schoolwork were found to be stable between the two school-closure periods.


Subject(s)
COVID-19 , Schools , Socioeconomic Factors , Humans , COVID-19/epidemiology , United Kingdom/epidemiology , Child , Male , Female , Adolescent , SARS-CoV-2 , Parents , Social Class , Education, Distance , Surveys and Questionnaires , Pandemics , Teleworking
2.
Zhonghua Yu Fang Yi Xue Za Zhi ; 58(6): 924-930, 2024 Jun 06.
Article in Chinese | MEDLINE | ID: mdl-38955743

ABSTRACT

Public health and social measures (PHSMs) are one of the most important measures in the prevention and control of COVID-19 and have also been effective in suppressing the spread of influenza viruses, but their effectiveness has not been fully investigated. This study aimed to review the progress of research on the impact of PHSMs on influenza during the COVID-19 pandemic based on the latest evidence of the effectiveness of various PHSMs in controlling transmission of influenza viruses, to provide scientific evidence for optimizing influenza prevention and control strategies.


Subject(s)
COVID-19 , Influenza, Human , Pandemics , Public Health , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Influenza, Human/epidemiology , Influenza, Human/prevention & control
3.
Cien Saude Colet ; 29(7): e03692024, 2024 Jul.
Article in Portuguese, English | MEDLINE | ID: mdl-38958326

ABSTRACT

This essay discusses the care process of health professionals in the context of COVID-19 from the perspectives of psychoanalysis, under the prism of Donald Winnicott's transitional space, and of collective health, under the prism of the practical wisdom of José Ricardo Ayres, the micropolitics of live work in action by Emmerson Merhy, and prudent care by Ruben Mattos. It suggests elaborating a care perspective to propose a possible resignification of illness in a pandemic, where health is marked with calamity, health catastrophe, and suffering and anguish, whether in the body or subjectively. In this way, understanding the manifestation of care by health professionals in a pandemic context brought about with narcissistic and heroic meanings and feelings of impotence and helplessness contributes to elaborating a creative conception of care. We conclude that the perspective of expanded care favors the creative possibility of new productions of meaning and support for professionals, resignifying their life experiences through love, creativity, practical wisdom, prudent care, live work in action, and motor imaginary.


Esse ensaio discute o processo de cuidado de profissionais de saúde no contexto da COVID-19 a partir das perspectivas da psicanálise, sob o prisma do espaço transicional de Donald Winnicott, e da saúde coletiva, sob o prisma da sabedoria prática de José Ricardo Ayres, da micropolítica do trabalho vivo em ato de Emmerson Merhy, e do cuidado prudente de Ruben Mattos. Propõe a elaboração de uma perspectiva de cuidado que se apresenta enquanto proposta de ressignificação possível ao adoecimento no contexto de pandemia, onde a saúde foi marcada com sentidos de calamidade e catástrofe sanitária, e expressões de sofrimento e angústia, no corpo e/ou mesmo subjetivamente. Desse modo, uma compreensão sobre a manifestação do cuidado do profissional de saúde, no contexto de pandemia, trazido com sentidos narcísicos e heroicos, e com sentidos de impotência e desamparo, contribui para a elaboração de uma concepção criativa do cuidado. Conclui-se que a perspectiva de um cuidado ampliado favorece a possibilidade criativa de novas produções de sentido e de sustentação para os profissionais, ressignificando suas experiências de vida, através do amor, da criatividade, da sabedoria prática, do cuidado prudente, do trabalho vivo em ato e do imaginário motor.


Subject(s)
COVID-19 , COVID-19/epidemiology , Humans , Health Personnel/psychology , Pandemics , Delivery of Health Care/organization & administration , Creativity
4.
Clin Invest Med ; 47(2): 4-11, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38958478

ABSTRACT

PURPOSE: The COVID-19 pandemic has resulted in a significant diagnostic, screening, and procedure backlog in Ontario. Engagement of key stakeholders in healthcare leadership positions is urgently needed to inform a comprehensive provincial recovery strategy. METHODS: A list of 20 policy recommendations addressing the diagnostic, screening and procedure backlog in Ontario were transformed into a national online survey. Policy recommendations were rated on a 7-point Likert scale (strongly agree to strongly disagree) and organized into those retained (≥75% strongly agree to somewhat agree), discarded (≥80% somewhat disagree to strongly disagree), and no consensus reached. Survey participants included a diverse sample of healthcare leaders with the potential to impact policy reform. RESULTS: Of 56 healthcare leaders invited to participate, there were 34 unique responses (61% response rate). Participants were from diverse clinical backgrounds, including surgical subspecialties, medicine, nursing, and healthcare administration and held institutional or provincial leadership positions. A total of 11 of 20 policy recommendations reached the threshold for consensus agreement with the remaining 9 having no consensus reached. CONCLUSION: Consensus agreement was reached among Canadian healthcare leaders on 11 policy recommendations to address the diagnostic, screening, and procedure backlog in Ontario. Recommendations included strategies to address patient information needs on expected wait times, expand health and human resource capacity, and streamline efficiencies to increase operating room output. No consensus was reached on the optimal funding strategy within the public system in Ontario or the appropriateness of implementing private funding models.


Subject(s)
COVID-19 , Pandemics , SARS-CoV-2 , Humans , COVID-19/epidemiology , COVID-19/diagnosis , Ontario/epidemiology , Surveys and Questionnaires , Leadership , Mass Screening , Delivery of Health Care , Male , Female , Health Personnel
5.
Front Endocrinol (Lausanne) ; 15: 1342204, 2024.
Article in English | MEDLINE | ID: mdl-38948513

ABSTRACT

Purpose: Chest computed tomography (CT) is used to determine the severity of COVID-19 pneumonia, and pneumonia is associated with hyponatremia. This study aims to explore the predictive value of the semi-quantitative CT visual score for hyponatremia in patients with COVID-19 to provide a reference for clinical practice. Methods: In this cross-sectional study, 343 patients with RT-PCR confirmed COVID-19, all patients underwent CT, and the severity of lung lesions was scored by radiologists using the semi-quantitative CT visual score. The risk factors of hyponatremia in COVID-19 patients were analyzed and combined with laboratory tests. The thyroid function changes caused by SARS-CoV-2 infection and their interaction with hyponatremia were also analyzed. Results: In patients with SARS-CoV-2 infection, the total severity score (TSS) of hyponatremia was higher [M(range), 3.5(2.5-5.5) vs 3.0(2.0-4.5) scores, P=0.001], implying that patients with hyponatremia had more severe lung lesions. The risk factors of hyponatremia in the multivariate regression model included age, vomiting, neutrophils, platelet, and total severity score. SARS-CoV-2 infection impacted thyroid function, and patients with hyponatremia showed a lower free triiodothyronine (3.1 ± 0.9 vs 3.7 ± 0.9, P=0.001) and thyroid stimulating hormone level [1.4(0.8-2.4) vs 2.2(1.2-3.4), P=0.038]. Conclusion: Semi-quantitative CT score can be used as a risk factor for hyponatremia in patients with COVID-19. There is a weak positive correlation between serum sodium and free triiodothyronine in patients with SARS-CoV-2 infection.


Subject(s)
COVID-19 , Hyponatremia , SARS-CoV-2 , Severity of Illness Index , Tomography, X-Ray Computed , Humans , COVID-19/complications , COVID-19/diagnostic imaging , Hyponatremia/etiology , Cross-Sectional Studies , Male , Female , Middle Aged , Risk Factors , Tomography, X-Ray Computed/methods , Aged , Adult , Pneumonia, Viral/complications , Pneumonia, Viral/diagnostic imaging , Coronavirus Infections/complications , Coronavirus Infections/diagnostic imaging , Pandemics , Betacoronavirus , Aged, 80 and over
6.
Int J Chron Obstruct Pulmon Dis ; 19: 1433-1445, 2024.
Article in English | MEDLINE | ID: mdl-38948907

ABSTRACT

Background: Exacerbations of chronic obstructive pulmonary disease (COPD) were reported less frequently during the COVID-19 pandemic. We report real-world data on COPD exacerbation rates before and during this pandemic. Methods: Exacerbation patterns were analysed using electronic medical records or claims data of patients with COPD before (2017-2019) and during the COVID-19 pandemic (2020 through early 2022) in France, Germany, Italy, the United Kingdom and the United States. Data from each country were analysed separately. The proportions of patients with COPD receiving maintenance treatment were also estimated. Results: The proportion of patients with exacerbations fell 45-78% across five countries in 2020 versus 2019. Exacerbation rates in most countries were reduced by >50% in 2020 compared with 2019. The proportions of patients with an exacerbation increased in most countries in 2021. Across each country, seasonal exacerbation increases seen during autumn and winter in pre-pandemic years were absent during the first year of the pandemic. The percentage of patients filling COPD prescriptions across each country increased by 4.53-22.13% in 2019 to 9.94-34.17% in 2021. Conclusion: Early, steep declines in exacerbation rates occurred in 2020 versus 2019 across all five countries and were accompanied by a loss of the seasonal pattern of exacerbation.


Subject(s)
COVID-19 , Disease Progression , Pulmonary Disease, Chronic Obstructive , Humans , COVID-19/epidemiology , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/physiopathology , Male , Female , Aged , Middle Aged , SARS-CoV-2 , United States/epidemiology , France/epidemiology , United Kingdom/epidemiology , Pandemics , Italy/epidemiology , Time Factors , Seasons
7.
Pediatr Ann ; 53(7): e249-e253, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38949870

ABSTRACT

Type 2 diabetes (T2D) is a growing concern among the pediatric population. During the coronavirus disease 2019 (COVID-19) pandemic, the incidence of pediatric T2D increased. This was more notable among males and Black people. Increased rates of T2D may be due to rising obesity rates observed during the pandemic, behavioral and nutritional changes due to the lockdown, and decreased structure typically provided by in-person schooling. New-onset T2D presentations are more severe than in years prior to the pandemic, with higher initial hemoglobin A1C levels and increased rates of diabetic ketoacidosis. Increased severity in presentation may be due to hesitation in seeking care, increased virtual care, and limited access to health care resources. The pathophysiology of the relationship between T2D and COVID-19 in youth is not clear at this time. More studies are needed to understand the true long-term impact of the COVID-19 pandemic on T2D in youth. [Pediatr Ann. 2024;53(7):e249-e253.].


Subject(s)
COVID-19 , Diabetes Mellitus, Type 2 , Humans , COVID-19/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Child , Adolescent , Male , Female , Incidence , SARS-CoV-2 , Pandemics , United States/epidemiology
9.
Health Aff (Millwood) ; 43(7): 970-978, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38950291

ABSTRACT

Although emergency department (ED) and hospital overcrowding were reported during the later parts of the COVID-19 pandemic, the true extent and potential causes of this overcrowding remain unclear. Using data on the traditional fee-for-service Medicare population, we examined patterns in ED and hospital use during the period 2019-22. We evaluated trends in ED visits, rates of admission from the ED, and thirty-day mortality, as well as measures suggestive of hospital capacity, including hospital Medicare census, length-of-stay, and discharge destination. We found that ED visits remained below baseline throughout the study period, with the standardized number of visits at the end of the study period being approximately 25 percent lower than baseline. Longer length-of-stay persisted through 2022, whereas hospital census was considerably above baseline until stabilizing just above baseline in 2022. Rates of discharge to postacute facilities initially declined and then leveled off at 2 percent below baseline in 2022. These results suggest that widespread reports of overcrowding were not driven by a resurgence in ED visits. Nonetheless, length-of-stay remains higher, presumably related to increased acuity and reduced available bed capacity in the postacute care system.


Subject(s)
COVID-19 , Emergency Service, Hospital , Length of Stay , Medicare , United States , Emergency Service, Hospital/statistics & numerical data , Emergency Service, Hospital/trends , Humans , COVID-19/epidemiology , Medicare/statistics & numerical data , Length of Stay/statistics & numerical data , Length of Stay/trends , Aged , Female , Pandemics , Male , Patient Discharge/statistics & numerical data , Patient Discharge/trends , SARS-CoV-2 , Hospitalization/statistics & numerical data , Hospitalization/trends , Hospital Bed Capacity/statistics & numerical data , Fee-for-Service Plans/trends , Crowding , Emergency Room Visits
10.
Health Aff (Millwood) ; 43(7): 909, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38950292
11.
Health Aff (Millwood) ; 43(7): 985-993, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38950293

ABSTRACT

Nursing home residents and staff were disproportionately affected by the COVID-19 pandemic, drawing attention to long-standing challenges of poor infection control, understaffing, and substandard quality of care in many facilities. Evolving practices and policies during the pandemic often focused on these challenges, with little effect. Despite the emergence of best practices to mitigate transmission of the virus, even the highest-quality facilities experienced outbreaks, indicating a larger systemic problem, rather than a quality problem at the facility level. Here we present a narrative review and discussion of the evolution of policies and practices and their effectiveness, drawing on evidence from the United States that was published during 2020-23. The lessons learned from this experience point to the need for more fundamental and nuanced changes to avoid similar outcomes from a future pandemic: greater integration of long-term care into public health planning, and ultimately a shift in the physical structure of nursing homes. More incremental measures such as vaccination mandates, higher staffing, and balancing infection control with resident quality of life will avoid some adverse outcomes, but without more systemic change, nursing home residents and staff will remain at substantial risk for repetition of the poor outcomes from the COVID-19 pandemic.


Subject(s)
COVID-19 , Infection Control , Nursing Homes , Aged , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Infection Control/organization & administration , Nursing Homes/standards , Pandemics , Quality of Health Care , United States/epidemiology
12.
Health Aff (Millwood) ; 43(7): 959-969, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38950300

ABSTRACT

Global supply chains for active pharmaceutical ingredients (APIs) are highly centralized in certain countries and are susceptible to supply-chain shocks. However, there is no systematic monitoring or global coordination to manage risk and ensure equitable supply continuity during public health emergencies. In this study, we applied quasi-experimental methods on shipment-level customs data to determine how prices and export volume for APIs exported from India were affected by the COVID-19 pandemic. We found that API prices for key essential medicines not used for COVID-19 did not change significantly in the year after the World Health Organization pandemic declaration, but volume decreased by 80 percent. Prices for medicines speculatively repurposed for COVID-19, such as hydroxychloroquine and ivermectin, increased by as much as 250 percent compared with prices for nonrepurposed medicines, but only ivermectin saw a decrease in volume. Systematic monitoring of API markets, investments to promote supply diversification, and legal and political reforms to disincentivize price speculation could support supply-chain resilience and safeguard access to medicines.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , SARS-CoV-2 , India , Commerce , COVID-19 Drug Treatment , Global Health , Drugs, Essential/supply & distribution , Drugs, Essential/economics , Ivermectin/supply & distribution , Ivermectin/therapeutic use , Ivermectin/economics , Pandemics , Internationality , Bulk Drugs
13.
Health Aff (Millwood) ; 43(7): 994-1002, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38950307

ABSTRACT

US health care use declined during the initial phase of the COVID-19 pandemic in 2020. Although utilization is known to have recovered in 2021 and 2022, it is unknown how revenue in 2020-22 varied by physician specialty and practice setting. This study linked medical claims from a large national federation of commercial health plans to physician and practice data to estimate pandemic-associated impacts on physician revenue (defined as payments to eligible physicians) by specialty and practice characteristics. Surgical specialties, emergency medicine, and medical subspecialties each experienced a greater than 9 percent adjusted gross revenue decline in 2020 relative to prepandemic baselines. By 2022, pathology and psychiatry revenue experienced robust recovery, whereas surgical and oncology revenue remained at or below baseline. Revenue recovery in 2022 was greater for physicians practicing in hospital-owned practices and in practices participating in accountable care organizations. Pandemic-associated revenue recovery in 2021 and 2022 varied by specialty and practice type. Given that physician financial instability is associated with health care consolidation and leaving practice, policy makers should closely monitor revenue trends among physicians in specialties or practice settings with sustained gross revenue reductions during the pandemic.


Subject(s)
COVID-19 , COVID-19/economics , COVID-19/epidemiology , Humans , United States , Physicians/economics , Pandemics/economics , Medicine/statistics & numerical data , SARS-CoV-2 , Specialization/economics
14.
Bull World Health Organ ; 102(7): 461-462, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38952428

ABSTRACT

The post-pandemic era presents an opportunity to prioritize health system performance assessment. Adèle Sulcas reports.


Subject(s)
Delivery of Health Care , Humans , Delivery of Health Care/organization & administration , COVID-19/epidemiology , Pandemics
15.
Article in English | MEDLINE | ID: mdl-38953003

ABSTRACT

Problem: While the COVID-19 pandemic threatened the entire world, the extremely remote Pitcairn Islands faced unique vulnerabilities. With only a physician and a nurse to care for an ageing population of fewer than 40 residents, and with very limited referral pathways, Pitcairn encountered distinct challenges in preparing for and responding to the COVID-19 pandemic. Context: The Pitcairn Islands is an overseas territory of United Kingdom of Great Britain and Northern Ireland consisting of four islands in the South Pacific: Pitcairn, Henderson, Ducie and Oeno. Pitcairn is the only inhabited island with a local resident population of approximately 31 people, around half of whom were over 60 years old in 2023. The islands are only accessible by sea and are located more than 2000 km from the nearest referral hospital in French Polynesia. Actions: Pitcairn's Island Council took aggressive action to delay the importation of SARS-CoV-2, vaccinate its small population and prepare for the potential arrival of the virus. Outcomes: As of May 2024, Pitcairn was one of the only jurisdictions in the world not to have had a single COVID-19 hospitalization or death. Nevertheless, the pandemic presented the islands' population with many economic, social and health challenges. Discussion: Pitcairn's population avoided COVID-19-related hospitalizations and deaths despite its elderly population's vulnerability to COVID-19, a significant level of comorbidities, and limited clinical management capabilities and options for emergency referrals. The pandemic highlighted some of the population's health vulnerabilities while also underscoring some of their innate strengths.


Subject(s)
COVID-19 , Pandemics , SARS-CoV-2 , Humans , COVID-19/epidemiology , COVID-19/prevention & control , United Kingdom/epidemiology , Pandemic Preparedness
16.
Eur J Public Health ; 34(Supplement_1): i74-i80, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946443

ABSTRACT

BACKGROUND: Global threats, such as the coronavirus disease 2019 (COVID-19) pandemic, have highlighted the critical importance of robust and well-functioning health information systems (HIS) in effectively addressing public health emergencies. To enhance the understanding and the functioning of such systems, it is crucial to perform HIS assessments. This article explores key gaps and identifies best practices in the COVID-19 HIS of eight European countries. Furthermore, it provides recommendations to strengthen European systems for better pandemic preparedness. METHODS: Assessments were carried out in eight European countries using an adapted version of the WHO support tool to strengthen HIS and the Joint Action on Health Information assessment tool. The assessments took place between January 2022 and April 2023. RESULTS: Four main themes emerged regarding the gaps and best practices identified in the various HIS: organizational, technical, legal and resources. The results of these assessments show different approaches implemented by countries to improve their HIS and respond to the demands of the pandemic. CONCLUSIONS: It is imperative for countries to draw valuable insights from the COVID-19 pandemic and strengthen their HIS. This involves the adaptation or development of pandemic preparedness plans, strengthening legislative framework for data sharing and privacy protection, promotion of data standards and international definitions and implementation of a unique person identifier. Additionally, countries will have to act in this post-pandemic era and integrate the newly developed systems and innovations into existing structures, maintain and develop trust by citizens through transparent communication and engage in infodemic management and address resource gaps in the workforce.


Subject(s)
COVID-19 , Health Information Systems , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Europe , Health Information Systems/standards , Health Information Systems/organization & administration , SARS-CoV-2 , Pandemics , Public Health , Information Dissemination/methods
17.
Eur J Public Health ; 34(Supplement_1): i11-i28, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946444

ABSTRACT

BACKGROUND: Contact tracing is a public health intervention implemented in synergy with other preventive measures to curb epidemics, like the coronavirus pandemic. The development and use of digital devices have increased worldwide to enhance the contact tracing process. The aim of the study was to evaluate the effectiveness and impact of tracking coronavirus disease 2019 (COVID-19) patients using digital solutions. METHODS: Observational studies on digital contact tracing (DCT), published 2020-21, in English were identified through a systematic literature review performed on nine online databases. An ad hoc form was used for data extraction of relevant information. Quality assessment of the included studies was performed with validated tools. A qualitative synthesis of the findings is reported. RESULTS: Over 8000 records were identified and 37 were included in the study: 24 modelling and 13 population-based studies. DCT improved the identification of close contacts of COVID-19 cases and reduced the effective reproduction number of COVID-19-related infections and deaths by over 60%. It impacted positively on societal and economic costs, in terms of lockdowns and use of resources, including staffing. Privacy and security issues were reported in 27 studies. CONCLUSIONS: DCT contributed to curbing the COVID-19 pandemic, especially with the high uptake rate of the devices and in combination with other public health measures, especially conventional contact tracing. The main barriers to the implementation of the devices are uptake rate, security and privacy issues. Public health digitalization and contact tracing are the keys to countries' emergency preparedness for future health crises.


Subject(s)
COVID-19 , Contact Tracing , Pandemics , SARS-CoV-2 , COVID-19/prevention & control , COVID-19/epidemiology , Humans , Contact Tracing/methods , Pandemics/prevention & control , Digital Technology , Public Health/methods
18.
Eur J Public Health ; 34(Supplement_1): i3-i10, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946440

ABSTRACT

BACKGROUND: During the first epidemic wave, COVID-19 surveillance focused on quantifying the magnitude and the escalation of a growing global health crisis. The scientific community first assessed risk through basic indicators, such as the number of cases or rates of new cases and deaths, and later began using other direct impact indicators to conduct more detailed analyses. We aimed at synthesizing the scientific community's contribution to assessing the direct impact of the COVID-19 pandemic on population health through indicators reported in research papers. METHODS: We conducted a rapid scoping review to identify and describe health indicators included in articles published between January 2020 and June 2021, using one strategy to search PubMed, EMBASE and WHO COVID-19 databases. Sixteen experts from European public health institutions screened papers and retrieved indicator characteristics. We also asked in an online survey how the health indicators were added to and used in policy documents in Europe. RESULTS: After reviewing 3891 records, we selected a final sample of 67 articles and 233 indicators. We identified 52 (22.3%) morbidity indicators from 33 articles, 105 severity indicators (45.1%, 27 articles) and 68 mortality indicators (29.2%, 51). Respondents from 22 countries completed 31 questionnaires, and the majority reported morbidity indicators (29, 93.5%), followed by mortality indicators (26, 83.9%). CONCLUSIONS: The indicators collated here might be useful to assess the impact of future pandemics. Therefore, their measurement should be standardized to allow for comparisons between settings, countries and different populations.


Subject(s)
COVID-19 , Humans , COVID-19/mortality , COVID-19/epidemiology , Europe/epidemiology , Health Status Indicators , Morbidity , Mortality/trends , Pandemics , Severity of Illness Index
19.
Eur J Public Health ; 34(Supplement_1): i35-i42, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946441

ABSTRACT

BACKGROUND: Before the COVID-19 pandemic, a need for a uniform approach to health information (HI) knowledge in population health analysis across Europe was evident. The Population Health Information Research Infrastructure (PHIRI) emerged as a proactive initiative to strengthen European HI capacities. This article describes the achievements of PHIRI, highlighting its capacity-building activities and their contribution towards a sustainable strategy for the implementation of the European Health Data Space (EHDS). METHODS: PHIRI collaboration established a work package for skill-building activities in population health in partnership with other organizations. Activities included webinars, workshops, sessions, training schools and courses for researchers and public administration workers from Europe and beyond. The primary goal of the activities was to examine the impact of COVID-19 on European health systems at both local and national levels, including healthcare facilities and policymaking entities. RESULTS: Twelve activities were organized between October 2020 and the summer of 2023. In March 2023, the Spring School on Health Information was organized to share the knowledge achieved from PHIRI and other European Union-related projects. This event also validated the European Health Information Training Programme. CONCLUSIONS: PHIRI's findings emphasized the importance of equipping the workforce with core HI skills to improve health systems' preparedness and resilience. Through this research, it is possible to propose a strategy for building capacity that emphasizes the importance of providing training in human-machine dynamics. This approach will contribute to the sustainable implementation of the EHDS.


Subject(s)
COVID-19 , Capacity Building , Humans , Europe , SARS-CoV-2 , Pandemics
20.
Eur J Public Health ; 34(Supplement_1): i50-i57, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946448

ABSTRACT

BACKGROUND: The indirect impact of the coronavirus disease 2019 pandemic on healthcare services was studied by assessing changes in the trend of the time to first treatment for women 18 or older who were diagnosed and treated for breast cancer between 2017 and 2021. METHODS: An observational retrospective longitudinal study based on aggregated data from four European Union (EU) countries/regions investigating the time it took to receive breast cancer treatment. We compiled outputs from a federated analysis to detect structural breakpoints, confirming the empirical breakpoints by differences between the trends observed and forecasted after March 2020. Finally, we built several segmented regressions to explore the association of contextual factors with the observed changes in treatment delays. RESULTS: We observed empirical structural breakpoints on the monthly median time to surgery trend in Aragon (ranging from 9.20 to 17.38 days), Marche (from 37.17 to 42.04 days) and Wales (from 28.67 to 35.08 days). On the contrary, no empirical structural breakpoints were observed in Belgium (ranging from 21.25 to 23.95 days) after the pandemic's beginning. Furthermore, we confirmed statistically significant differences between the observed trend and the forecasts for Aragon and Wales. Finally, we found the interaction between the region and the pandemic's start (before/after March 2020) significantly associated with the trend of delayed breast cancer treatment at the population level. CONCLUSIONS: Although they were not clinically relevant, only Aragon and Wales showed significant differences with expected delays after March 2020. However, experiences differed between countries/regions, pointing to structural factors other than the pandemic.


Subject(s)
Breast Neoplasms , COVID-19 , SARS-CoV-2 , Time-to-Treatment , Humans , COVID-19/epidemiology , Breast Neoplasms/therapy , Female , Longitudinal Studies , Retrospective Studies , Time-to-Treatment/statistics & numerical data , Middle Aged , Pandemics , Adult , Aged , European Union , Population Health , Treatment Delay
SELECTION OF CITATIONS
SEARCH DETAIL